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Abstract
Background: Globally, antimicrobial drug–resistant Escherichia coli is among the most common etiological
agents of invasive disease in humans. In Europe, increasing proportions of infections due to third-generation
cephalosporins and/or fluoroquinolone-resistant extraintestinal pathogenic E. coli (ExPEC) strains are reported.
E. coli from poultry are those more closely linked to human E. coli, but lack of reliable data makes it difficult to
assess the attributable risk of different food sources. In the present study, our objective was to investigate the
antimicrobial resistance profile, phylogenetic background, and virulence factors of E. coli isolates from broiler
chicken meat sold at retail in Palermo, Italy.
Materials and Methods: Isolation of multidrug resistant (MDR) E. coli was performed during April–December
2013 on a total of 163 chicken meat samples. Susceptibility to a panel of nine antimicrobial agents was
determined. PCR assays were carried out to detect extended-spectrum b-lactamase (ESBL), plasmid-mediated
AmpC b-lactamase, and plasmid-mediated quinolone resistance (PMQR) genes, phylogenetic group, and Ex-
PEC-associated traits. A single nucleotide polymorphism (SNP) PCR was done to detect E. coli sequence type
(ST)131.
Results: One hundred thirty-four isolates from 109 meat samples were MDR. B1 was the most prevalent
phylogenetic group (47.8%), followed by groups D (25.4%), A (22.3%), and B2 (4.5%). ESBLs and AmpC b-
lactamases were detected by PCR in 132 (98.5%) and 15 (11.2%) isolates. PMQR determinants were detected in
122 (91%) isolates. Twenty-two MDR isolates met the molecular definition of ExPEC. SNP-PCR results
confirmed that four B2 isolates were ST131. Enterobacterial Repetitive Intergenic Consensus sequence–PCR
analysis showed a large heterogeneity with 55 unique profiles and 31 clusters including 2–4 isolates.
Conclusions: An alarmingly high prevalence of MDR E. coli from broiler chicken meat is evident in our
geographic area. The ongoing use of antimicrobial drugs in livestock should be urgently restricted, particularly
in the poultry sector.
Introduction
Escherichia coli, a commensal bacterium that is usu-ally found in the intestinal tract of humans and animals,
can cause healthcare- and community-acquired infections
including urinary tract, postsurgical, and systemic infections,
based upon their virulence gene content and antibacterial
drug resistance (Pitout, 2012). Extraintestinal pathogenic
E. coli (ExPEC), the distinctive E. coli strains that possess the
specialized virulence factors required for extraintestinal
disease, are of particular concern. They can be, indeed, as-
sociated with animal and human infections, such as urinary
tract and bloodstream infections. Acquired antimicrobial
resistance is particularly concerning when it occurs in ExPEC
(Johnson et al., 2005b, 2010; Pitout et al., 2012).
Antibiotics in livestock production are used for a variety of
reasons, such as infectious disease treatment, prevention,
control, and growth promotion/feed efficiency (Anderson,
2003; DANMAP, 2010). However, any use of antimicrobial
drugs, mainly low-dose, prolonged courses among food an-
imals, will select for antibiotic-resistant bacteria, which in
turn will spread by direct contact or through food, water, and
animal waste application to farm fields (Finley et al., 2013;
Millman et al., 2013). Methods of livestock production differ
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in antibiotic use, influencing the prevalence of antibiotic-
resistant bacteria on retail meats (Millman et al., 2013).
Extended-spectrum b-lactamase (ESBL) and AmpC-
producing E. coli are associated with localized or systemic
disease in humans (Reich et al., 2013). Resistance genes
coding ESBLs are mostly plasmid associated and therefore
can easily horizontally spread among E. coli strains. Ad-
ditionally, although chromosomal AmpC genes exist in
several enterobacteria including E. coli, plasmid-bound types
can be also present (Nikaido, 2009). Emergence of resistance
to fluoroquinolones that, because of their low toxicity and
relatively broad-spectrum coverage, are widely employed
tools for treating human infections, is of particular concern
(Angulo et al., 2000; Livermore et al., 2002; Literak et al.,
2013).
There are many reports in the literature describing the
molecular characteristics of E. coli isolates from human
clinical samples and animals, and several studies have ex-
amined the degree of molecular similarities between patho-
genic isolates of either origin ( Johnson et al., 2005a, 2007;
Jakobsen et al., 2010; Kluytmans et al., 2013a). The role of
E. coli isolates from foods of animal origin as a link between
the livestock niche and humans is of special interest.
In this study, our objective was to investigate phylogenetic
background, antimicrobial resistance profile, virulence fac-
tors, and their association in E. coli isolates recovered from
retail broiler chicken meat on sale in Sicily, Italy.
Materials and Methods
Bacterial isolates
A total of 163 chicken broiler meat samples were bought
from a range of retail grocery stores in Palermo, Italy, during
April–September 2013. According to labeling, chicken had
been conventionally raised in Italy. A 5-g portion of each
specimen was added to 45 mL of modified trypticase soy
broth, containing 20 mg/L of novobiocin (Sigma Chemical
Co., St. Louis, MO). The enrichment cultures were incubated
at 37C for 18–24 h and then subcultured as a continuous
lawn onto MacConkey agar plates. Antibiotic disks con-
taining ceftazidime (30lg), ciprofloxacin (5lg), and cefox-
itin (30 lg) were placed on each plate before incubation.
One lactose-positive colony of each morphologically differ-
ent type, growing into the antibiotic inhibition haloes, was
picked up, subcultured, and presumptively identified as
E. coli by indole, citrate, methyl red, and Voges-Proskauer
tests. To confirm identification, polymerase chain reaction
(PCR) amplifications of trpA gene, as a species-specific gene,
for E. coli was performed (Clermont et al., 2009).
Antimicrobial susceptibility and ESBL/AmpC status
Susceptibility to 10 antimicrobial agents including
amoxicillin–clavulanic acid (20–10 lg), ciprofloxacin
(5 lg), cefotaxime (30 lg), cefoxitin (30lg), ceftazidime
(30 lg), cefepime (30lg), gentamicin (10lg), imipenem
(10 lg), sulfamethoxazole–trimethoprim (25 lg), and tetra-
cycline (30 lg) was determined by disk diffusion and inter-
preted according with the EUCAST (European Committee
on Antimicrobial Susceptibility Testing) guidelines (http://
www.eucast.org/clinical_breakpoints/). Intermediately re-
sistant isolates were categorized as resistant. Production of
ESBLs was determined by the double-disk synergy test
(DDST) phenotypic confirmatory test, and AmpC expression
was evaluated by a modified three-dimensional test (Man-
chanda and Singh, 2003). For the purposes of the study,
isolates exhibiting resistance to at least three antibacterial
drug classes (amoxicillin–clavulanic acid, third-generation
cephalosporins, cefepime, carbapenems, fluoroquinolones,
aminoglycosides, sulfamethoxazole–trimethoprim, and tet-
racycline) were defined as multidrug resistant (MDR).
Phylogenetic grouping by multiplex PCR
Phylogenetic group was determined using a triplex PCR
according with Clermont et al. (2000).
Multiplex PCR assay for ESBLs and AmpC detection
Three multiplex PCRs were used: (1) blaTEM/blaSHV/
blaOXA-1-like PCR; (2) blaCTX-M PCR including groups 1, 2,
and 9; and (3) a plasmid-mediated AmpC b-lactamase gene
targeting PCR including six groups (i.e., ACC, FOX, MOX,
DHA, CIT, and EBC) (Dallenne et al., 2010). As positive
controls, we used previously characterized isolates from our
collection carrying all types of tested b-lactamases.
Detection of plasmid-mediated quinolone resistance
(PMQR) determinants
All isolates were investigated for the presence of qnrA,
qnrB, qnrS, and aac(6¢)-Ib genes according with Cavaco
et al. (2008). As positive controls, previously characterized
isolates carrying the PMQR gene sequences under study
were used.
Virulence genotyping
All isolates belonging to phylogenetic groups B2 and D
were investigated for the following eight ExPEC-related
virulence genes by two quadruplex PCRs ( Johnson et al.,
2005b). Four strains were used as positive controls in the
PCR screening: E. coli RS218 (kpsMT II, papA, papC, sfaS,
hlyD), E. coli V27 (kpsMT II, papA, papC, iutA, focG), E. coli
2H16 ( papC, iutA, afa, hlyD), and E. coli J96 ( papA, focG).
E. coli MG1655 was used as a negative control in the reac-
tions. All the reference E. coli strains were kindly provided
by James R. Johnson (VA Medical Center, Minneapolis,
MN). E. coli isolates were defined as ExPEC if they tested
positive for at least two of papA and/or papC, sfa/foc, afa/dra,
kpsMT II, and iutA genes ( Johnson et al., 2005b).
Detection of ST131
All group B2 isolates were screened by PCR for the
ST131-associated single nucleotide polymorphisms (SNPs)
in mdh and gyrB ( Johnson et al., 2010). E. coli strains
MVAST131, jj2663, and BUTI 1-2-1 (H17) were used as
positive control strains.
ERIC-PCR analysis
Enterobacterial Repetitive Intergenic Consensus sequence
polymerase chain reaction (ERIC-PCR) was performed on all
isolates (Wilson et al., 2006). BioNumerics software, version
6.1, (Applied Maths, Sint-Martens-Laten, Belgium) was used
for analyzing the ERIC-PCR fingerprints. The similarities in
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amplicon profiles were compared using a Dice coefficient at
1% tolerance and 0.5% optimization, and a dendrogram was
constructed with the unweighted-pair group method with
arithmetic mean clustering method with a cut-off of 80%
similarity (McLellan et al., 2003).
Results
All 163 chicken meat samples under investigation grew
E. coli and 109 (66.9%) yielded isolates resistant to ceftazi-
dime, ciprofloxacin, or both. In particular, E. coli isolates
resistant to ceftazidime were found in 95 samples of 109
(87.1%), to cefoxitin in 24 samples (22.0%), and to cipro-
floxacin in 109 samples (100.0%), respectively. One hundred
thirty-fourE. coliwere isolated from the 109 meat samples and
further analyzed. Their resistance pattern can be summarized as
follows: 92 (68.7%) were resistant to amoxicillin–clavulanic
acid, 123 (91.7%) to cefotaxime, 123 (91.7%) to ceftazidime,
23 (17.1%) to cefepime, 24 (17.9%) to cefoxitin, 119 isolates
(88.8%) to ciprofloxacin, 19 (14.1%) to gentamicin, 106
(79.1%) to sulfamethoxazole–trimethoprim, and 123 (91.8%)
to tetracycline. None was resistant to imipenem (Table 1).
All of the 134 isolates tested positive for ESBL production
by DDST. A putative AmpC expression by the 3-dimensional
test with cefoxitin disk was detected in 24 cefoxitin-resistant
isolates. All of the 134 isolates met the criteria for the defi-
nition of MDR.
Phylogenetic group B1 was the most prevalent (64 isolates,
47.8%) followed by groups D (34 isolates, 25.4%), A (30
isolates, 22.3%), and B2 (six isolates, 4.5%). Table 1 de-
scribes frequency of resistance to the antibacterial drugs
tested according to phylogroups.
ESBLs and AmpC b-lactamases were detected by PCR in
132 (98.5%) and 15 (11.2%) isolates, respectively, while
PMQR determinants were detected in 122 (91%) of isolates.
Moreover, all isolates testing positive for the PMQR genes
carried also ESBL gene determinants. In particular, 90 iso-
lates (67.2%) tested positive for SHV, 104 (77.6%) for TEM,
and 65 (48.5%) for both TEM and SHV. None of the isolates
was positive for the OXA-1-like gene. Twelve isolates
(8.9%) were positive for CTX-M-1 group, 23 isolates
(17.2%) for CTX-M-2 group and 10 isolates (7.5%) for CTX-
M-9 group, respectively. Fifteen isolates (11.2%) carried
AmpC genes which all proved to be CIT-like. Two isolates of
D phylogroup were positive for SHV, TEM, CTX-M, and
plasmidic AmpC b-lactamases. Among the PMQR determi-
nants, only qnrA was detected in all fluoroquinolone-resistant
isolates. The differential distribution of the ESBL, AmpC,
and PMQR genes under study according with the phylogroup
is shown in Figure 1. Phylogroup D isolates carried CTX-M
more frequently than phylogroups A and B1 isolates (D, 16 of
34 isolates [47.0%] versus A, 9 of 30 isolates [30.0%] and B1,
15 of 64 [23.4%], respectively) and Amp-C (D, 11 of 34
isolates [32.3%] versus A, no isolate and B1, 3 of 64 [4.7%],
respectively) genes. Two and one B2 isolates, respectively,
tested positive for CTX-M and AmpC.
Based on the molecular definition of ExPEC, 22 isolates of
40 belonging to phylogroups B2 and D were attributed with
the status of ExPEC (all the B2 isolates and 16 of 34 [47.1%]
D isolates). The most prevalent virulence factors were kpsMT
II and iutA. SNP-PCR results confirmed that 4 isolates of
phylogroup B2 were ST131. These four isolates were positive
for both ESBL and PMQR determinants.
The ERIC-PCR analysis showed that 79 of the 134 E. coli
isolates belonged to 31 different clusters including between 2
and 6 isolates each, whereas the remaining 55 were singletons
(Fig. 2). Isolates belonging to phylogroup D were more likely
to be clustered (26 of 34 isolates [76.5%] included into 10
clusters) than those belonging to phylogroups B1 (40 of 64
isolates [62.5%] included into 15 clusters) and A (11 of 30
isolates [36.7%] included into 5 clusters) (Fig. 2).
Discussion
Antimicrobial resistance is an issue of great concern be-
cause of the serious limitation and even the risk for loss of
effective antimicrobial treatment of infections. There are un-
deniable evidences that foods from many different animal
sources and in all stages of processing contain resistant bac-
teria and their resistance genes (Cabello et al., 2006; Dierikx
et al., 2013). It has also been documented that they can be
transferred to humans (Witte, 2000; Perreten, 2005; Cabello
et al., 2006). According to the literature, antimicrobial-
resistant E. coli strains carried by healthy animals seem to
link directly with human infection cases (Marshall and Levy,
2011). In particular, studies about bloodstream infections
caused by E. coli in Europe suggest that poultry might be an
important source of resistant isolates ( Johnson et al., 2006;
Johnson et al., 2007; Vieira et al., 2011).
In this study, MDR E. coli were recovered from 66.9% of
poultry meat samples on sale in Palermo, Italy. These results
appear to be consistent with findings from other European
Table 1. Frequency of Resistance to the Antibacterial Drugs Under Study Among
the 134 Multidrug-Resistant Isolates by Phylogenetic Group
Antibacterial druga
Phylogenetic group AMC CAZ CTX FEP FOX GEN CIP SXT TET
(no. isolates) no. (%) no. (%) no. (%) no. (%) no. (%) no. (%) no. (%) no. (%) no. (%)
A (30) 21 (70.0) 26 (87.0) 26 (87.0) 3 (10.0) 0 (0.0) 4 (13.3) 23 (76.7) 21 (70.0) 27 (90.0)
B1 (64) 49 (76.5) 62 (96.8) 62 (96.8) 17 (26.5) 7 (10.9) 8 (12.5) 58 (90.6) 51 (79.7) 60 (93.7)
B2 (6) 3 (50.0) 6 (100) 6 (100) 3 (50.0) 1 (16.7) 0 (0.0) 6 (100) 2 (33.3) 6 (100)
D (34) 19 (55.9) 29 (85.3) 29 (85.3) 8 (23.5) 16 (47) 4 (11.8) 32 (94.1) 32 (94.1) 30 (88.2)
aTested by the disk-diffusion method.
AMC, amoxicillin–clavulanic acid; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; FOX, cefoxitin; GEN, gentamicin; CIP,
ciprofloxacin; SXT, sulfamethoxazole–trimethoprim; TET, tetracycline.
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and non-European countries (EFSA Panel on Biological
Hazards, 2011). In three similar studies in Portugal, Spain,
and the Netherlands, indeed, MDR E. coli strains were iso-
lated in 60%, 90%, and 94% of chicken carcasses at the retail
level, respectively (Costa et al., 2009; Cohen Stuart et al.,
2012; Silva et al., 2012). However, results from different
studies are difficult to compare because of different settings
and sample-processing methods. Our findings also can be
cautiously compared with those of previous studies because
of our MDR E. coli detection approach.
All the MDR E. coli isolates tested phenotypically positive
for ESBLs and in a lower proportion for AmpC b-lactamases.
In 3 similar studies in Germany, Spain, and the Netherlands,
ESBLs were found in 88.6%, 79.7%, and 79.8%, respec-
tively, of chicken carcasses, fecal samples, and meat, re-
spectively (Costa et al., 2009; Cohen Stuart et al., 2012;
Reich et al., 2013). Again, our detection method makes it
difficult to meaningfully compare our ESBL-producing E.
coli prevalence with those previously reported.
The predominant ESBL gene families among our E. coli
isolates were blaSHV, blaTEM, and blaCTX-M-1 group, which is
comparable with previous data from European countries.
TEM, SHV, and CTX-M-1 group are reported as the most
prevalent b-lactam resistance determinants in the food animal
reservoir (Costa et al., 2009; Cohen Stuart et al., 2012; Reich
et al., 2013). AmpC b-lactamases are less frequently reported
among E. coli isolates, with the family CMY-2 being the most
prevalent worldwide. Likewise, in our study a prevalence of
about 10% plasmid-mediated AmpC-producing E. coli was
detected (Cohen Stuart et al., 2012). However, plasmidic
AmpC was always attributed with the CIT-like type. The
absence of AmpC genes in some phenotypically positive
isolates might indicate a different mechanism of resistance,
such as overexpression of chromosomal AmpC (Peter-
Getzlaff et al., 2011).
The prevalence of plasmid-mediated quinolone resistance
was very high among our isolates, which highlights a serious
clinical and public health issue of concern. qnrA was the only
PMQR determinant detected in all ciprofloxacin resistant
isolates accounting for a prevalence of about 90%, substan-
tially higher than any other previous report. For instance, in
two studies from Czech Republic and Portugal, PMQR genes
were detected only in 4% and 5.5% of strains, respectively
(Literak et al., 2013; Jones-Dias et al., 2013). This finding
could be tentatively related to the extensive use of fluor-
oquinolones in the poultry industry in the southern European
countries, including Italy (Cerquetti et al., 2009). Transmis-
sion of qnr-positive E. coli isolates to humans through the
food chain has been previously hypothesized (Fa`brega et al.,
2008).
The majority of the isolates in our study belonged to the
phylogenetic group B1, followed by groups D, A and B2.
These results are consistent with previously reports from both
European and non-European countries (Hannah et al., 2009;
Lyhs et al., 2012; Obeng et al., 2012; Hiki et al., 2014).
Interestingly, according with Walk et al. (2007), the majority
of the E. coli strains able to persist in the environment belong
to the B1 phylogenetic group.
Special attention has been focused on retail meat as a ve-
hicle for transmission of ExPEC from animals to humans
( Johnson et al., 2005b). Within our collection, 22 (16.4%) E.
coli isolates could be classified as ExPEC. Johnson et al.
(2005b) found 21% of 110 E. coli isolates from chicken
products to meet the criteria for ExPEC identification. In a
further study by Lyhs et al. (2012), 22% of E. coli strains
from chicken samples could be classified as ExPEC. Xia et al.
(2011) found the highest rate of ExPEC strains among dif-
ferent retail meats in ground turkey (23.5%) and chicken
breasts (20.2%). Of interest, our D isolates were more fre-
quently antibiotic-resistant, ESBL and AmpC carrying
compared with those belonging to phylogroups A and B1,
which is consistent with literature reporting a close combi-
nation of antibiotic resistance and virulence traits (Pitout,
2012). B2 phylogroup isolates behaved similarly but their
limited number does not allow meaningful conclusions to
be drawn.
FIG. 1. Distribution of the resistance genetic determinants under study by phylogroup.
622 GHODOUSI ET AL.
Genotyping by the ERIC-PCR method showed 55 unique
DNA banding profiles and a proportion of &60% of isolates
grouped into 31 small clusters. These findings support a high
genetic heterogeneity of E. coli isolates, despite their isola-
tion in a restricted geographic area. Such a finding is a further
source of concern, emphasizing that emergence of MDR
E. coli in chicken is not resulting from the clonal expansion of
a few successful bacterial strains, but more likely from a
complex interaction between several different clones and
laterally transferred resistance genes (Olsen et al., 2014).
Our study has some limitations. First, a relatively small
number of samples were analyzed from a restricted geo-
graphic area. This, because of the presumable homogeneity
of the husbandry techniques, could lead to an overestimate of
the prevalence of MDR E. coli. On the other hand, our mi-
crobiological approach could have determined an underesti-
mate of the heterogeneity of the cephalosporin- and/or
ciprofloxacin-resistant E. coli isolates and biased our evalu-
ations. Moreover, selection of only lactose-positive colonies
might have further contributed to underdetecting samples
containing MDR E. coli. Characterization of resistance
genetic determinants was not further defined because the
wide heterogeneity of their distribution made this approach
unaffordable.
In summary, our results show that in Sicily a large pro-
portion of retail chicken meat samples carry cephalosporin-
and ciprofloxacin-resistant E. coli. A high prevalence of
ESBL and PMQR determinants was also found in these iso-
lates, which raises a serious public health concern. A prudent
use of antimicrobial agents is urgent in veterinary as well
as in human medicine to minimize the selection and spread
of antibiotic-resistant strains and their resistance genetic
determinants.
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